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Abstract
Despite extensive diagnostic evaluation and numerous treatment trials, a number of patients
remain troubled by a chronic and uncontrollable cough. Eosinophilic bronchitis, atopic cough and
non-acid reflux have been recently added to the diagnostic spectrum for chronic cough. In some
cases, failure to consider these conditions may explain treatment failure. However, a subset of
patients with persisting symptoms may be regarded as having an idiopathic cough. These individuals
are most commonly female, of postmenopausal age and frequently report viral upper respiratory
tract infections as an initiating event. This paper seeks to explore the validity of idiopathic cough as
a distinct clinical entity.
Introduction
Despite considerable advance in the understanding of
cough, the effective management of patients with a
chronic cough can be difficult. For the patient, a cough
which persists can be associated with considerable distress
and impaired quality of life [1]. For the physician, failure
to obtain a treatment response may lead to the mistaken
belief that the cough is functional or psychogenic. There
are a number of reasons why the cough may be difficult to
treat. In some cases it may reflect an inadequate approach
to diagnostic evaluation and failure to appreciate both
pulmonary and extra pulmonary causes for chronic cough
[2,3]. In other cases, trials of therapy may be of inade-
quate dose and of insufficient duration. However, an
alternative explanation is that a distinct diagnostic entity
exists, namely idiopathic cough [4]. If this is the case then
almost nothing is known about the underlying patho-
physiological processes responsible for this condition and
at present there are no effective treatment options. This
article seeks to examine the evidence for idiopathic cough
as either a distinct diagnosis or simply the result of incom-
plete evaluation and inadequate courses of therapy.
Diagnostic protocols for chronic cough
The term 'idiopathic' comes from the Greek word idio-
patheia and is defined in the Oxford English Dictionary as
a 'disease not preceded or occasioned by another, or by
any known cause' [5]. In the original description of cough
evaluation and management by Irwin and colleagues, idi-
opathic cough was not described and indeed treatment
failure was extremely rare [6]. Using a stepwise approach
known as the anatomic diagnostic protocol, Irwin and
colleagues reported that a cause for cough could be deter-
mined successfully in up to 98% of cases and was due to
either cough variant asthma (CVA), rhinosinusitis associ-
ated with postnasal drip syndrome (PNDS) or gastro-
oesophageal reflux disease (GORD) [6]. The subsequent
experience from this group [7,8] and a number of others
in hospital-based settings [9,10] has remained the same
and the diagnostic protocol has been recommended by
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guidelines for the management of cough [11].
Although the systematic evaluation of both extrapulmo-
nary and pulmonary causes for cough is widely held to be
effective, doubt has been cast on the perception that the
diagnostic triad of CVA, PNDS and GORD accounts for
the almost all causes of chronic cough [12,13]. Despite
adopting a comprehensive evaluation of patients referred
with cough, many groups have reported diagnostic and
treatment failure in anything from 12 – 42% of patients
[14-16]. For some, this represents a population with idio-
pathic cough [16] but others suggest it reflects failed man-
agement [17]. Specifically, the failure to prescribe sedating
antihistamines for postnasal drip syndromes [17] and the
inadequate treatment of gastro-oesophageal reflux disease
have been highlighted [18].
There are a number of possible explanations for the
impressive treatment response described by Irwin and
others. Firstly, it is probable that the original referral pop-
ulations included patients with cough following a viral
upper respiratory infection. It is now recognised that
cough following an upper respiratory tract infection may
persist beyond three weeks and only resolve spontane-
ously some weeks or months later. Therefore some of the
'treatment success' may merely have reflected the natural
resolution of a prolonged post-viral cough. Secondly,
many patients were prescribed older generation antihista-
mines, which have an imprecise pharmacological action
but presumably exert most of their antitussive effect by
crossing the blood-brain barrier and acting directly on the
cough control centre within the brain. Crucially, response
to such therapy tells us little about the aetiology of the
cough. Finally, these original studies reported on short-
term treatment outcomes and provided little information
on the long-term treatment response. Initial treatment
benefit may well diminish over time and the timing of
patient follow-up may explain some of the variance in
outcome described by different centres [19].
Failure to adequately treat cough
Current guidelines have recommended a combination of
diagnostic testing and empirical trials in the management
chronic cough [20]. Some authors have reported that the
characteristics of a cough confer little diagnostic informa-
tion [21] but in practice, prominent symptoms of an
upper airway disorder or indigestion should prompt a
treatment trial of anti-rhinitic therapy or anti-reflux ther-
apy [20]. The question of how much and for how long of
a specific treatment has yet to be unequivocally answered.
This point is perhaps best illustrated in the management
of GORD associated cough. Although lacking a strong evi-
dence base, it may be necessary to embark on intensive
courses of anti-reflux therapy, because in contrast to the
symptoms of heartburn, which usually resolve after a few
days treatment, improvement in cough seems to take
much longer [18,22]. In one study, mean duration to
treatment success was 179 days [18]. As a consequence,
failure to comply with prolonged therapy and lifestyle
changes may result in relapse and explain poor treatment
success even in patients with a high suspicion of GORD
associated cough [19].
Alternatively, some individuals on relatively high doses of
acid suppression may exhibit relative proton pump ther-
apy resistance. This is particularly the case with attempts
to suppress proximal and laryngophayngeal reflux where
despite single and higher dose treatment regimes, 44% of
patients demonstrated abnormal levels of acid exposure
on simultaneous oesophagel and laryngeal pH testing
[23]. Finally, a minority of patients who fail adequate
courses of acid suppressive therapy may ultimately require
anti-reflux surgery [24]. This final observation has con-
tributed to the growing appreciation that acid may not be
the sole aggravating factor in gastric refluxate. Until
recently, this concept of 'non-acid reflux' as a cause for
cough had been infrequently considered. It will be dis-
cussed together with a number of other 'new causes for
cough' in the subsequent section of this review.
New causes for cough
Given the extent of associated literature, it is barely con-
ceivable that any respiratory physician is unaware of the
most common associations with chronic cough, namely
asthma, GORD and rhinosinusitis, more recently termed
upper airway cough syndrome. In the last decade, a series
of important observations have led to the appreciation of
new diagnostic possibilities. Most importantly, the appli-
cation of induced sputum in the evaluation of cough has
led to the identification of eosinophilic airway syndromes
[25]. These conditions are characterized by the presence of
eosinophilic airway inflammation but crucially the
absence of the airway dysfunction (airflow variability or
bronchial hyperreactivity) normally attributed to asthma.
The best-described condition is eosinophilic bronchitis,
which may account for up to 15% of patients referred to
hospital with chronic cough [26]. It frequently responds
to inhaled corticosteroids, and as these are often pre-
scribed empirically in the community the exact prevalence
of this condition is unknown. More recently, a number of
Japanese groups have described a syndrome of "Atopic
Cough" [27]. These patients are atopic, have an isolated
bronchodilator resistant cough and an eosinophilic tra-
cheobronchitis. Like eosinophilic bronchitis, there is no
evidence of airway hyperreactivity but in contrast, the
cough does not respond to inhaled corticosteroids. With-
out adequate attention to the inflammatory characteristics
of the airway, and reluctance to prescribe inhaled steroids
to patients with normal airway function then either ofPage 2 of 5
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idiopathic cough.
The concept of 'Non-acid reflux' has recently gained atten-
tion. Irwin and colleagues [24] reported on a group of 8
patients that had persistent cough despite total or near
total acid suppression utilizing proton pump inhibitors,
prokinetic agents and antireflux diet (omeprazole 20–80
mg p.o. daily and cisapride 40–80 mg p.o. daily). These 8
patients had 24 hour ambulatory oesophageal pH moni-
toring while on medical therapy, and in all patients the %
of 24 hours spent at pH < 4.0 was zero or near zero.
Despite this, all 8 patients underwent antireflux surgery
with marked reduction in cough scores after surgery,
which were maintained after 12 months of follow up. This
study suggests antireflux surgery may improve cough that
is resistant to medical therapy, and that the improvement
is sustained. Acid reflux disease in patients with cough
and GORD may be a misnomer since non-acid reflux may
be responsible for cough in some patients (volume reflux
with gastric enzymes, bile salts etc.) [28]. Thus failure to
respond to antireflux therapy may not indicate an idio-
pathic chronic cough.
Finally an association between cough, GORD and a famil-
ial sensory neuropathy has recently been reported [29].
The locus for the particular gene appears to be located on
chromosone 3. In a series of personal communications
with other cough specialists, it would appear similar asso-
ciations have been encountered suggesting such clinical
features may represent a new cough syndrome.
The common and less common associations with cough
must be rigorously excluded before a diagnosis of idio-
pathic cough can be assigned. None-the-less, this author
firmly believes such a condition exists and it will be
addressed in some detail in the following section.
Idiopathic cough as a distinct clinical entity
The accumulation of experience and information regard-
ing idiopathic cough suggests a fairly well defined popu-
lation of patients. The over-representation of women in
the specialist cough clinic referral population is widely
acknowledged, and the preponderance of females among
idiopathic coughers is particularly striking. Some centers
have reported female prevalence rates of more than 80%
[14-16,30-33] (See table 1). Gender differences in health-
related quality of life and as a consequence differences in
health seeking behaviour is one explanation [34] but oth-
ers have suggested a distinct clinical phenotype [4]. Typi-
cally the female patients are of peri- or post menopausal
age, report a preceding upper respiratory tract infection
(URTI) and have a heightened cough reflex to tussive
stimuli [16]. These observations raise the possibility that
sex hormones and viral URTIs in some way contribute to
the development of an idiopathic cough in susceptible
individuals.
Possible mechanisms for idiopathic cough
The human cough reflex consists of an afferent arm com-
prising cough receptors, afferent pathways, central
processing and an efferent pathway. The cough reflex can
be modified at any point along this reflex and unraveling
the mechanisms responsible is key to a more complete
understanding of cough pathophysiology and its success-
ful treatment. Afferent sensory nerves are not static entities
and the term 'plasticity' has been used to describe changes
in function contributing to the sensitization that occurs in
response to various stimuli, in particular those associated
with airway inflammatory processes [35]. Although viral
infections are a major cause of cough and appear to be fre-
quently reported in patients with idiopathic cough, little
is known regarding the effects of viruses on cough sensi-
tivity. Following respiratory syncytial virus infection in
rats, tachykinin content within the lung is increased [36]
along with an upregulation in the substance P receptor,
neurokinin (NK) 1 [37]. These changes appear to persist
for some time after the virus is cleared. In guinea pigs,
inoculation with the Sendai virus has been associated
with a qualitative change in airway sensory nerves
whereby nonnociceptive neurons express tachykinins
[38]. This 'phenotypic switch' is one plausible mechanism
whereby viral infection causes increased tachykinergic
content in airway nerves which possibly contribute to per-
sistent reflex hypersensitivity and cough. It is unknown if
such processes occur in man, but abnormal intraepithelial
nerves containing increased neuropeptide content have
been reported in bronchial biopsies from patients with
idiopathic cough [39].
Only a few studies have specifically commented on find-
ings in the airways of patients with idiopathic cough. Bir-
ring et al. observed a mild chronic lymphocytic airway
inflammation in a predominately female population of
idiopathic coughers and highlighted the striking associa-
tion with organ specific autoimmune disease in particular
hypothyroidism [40]. They suggested that the presence of
increased lymphocytes within the airway reflected either
an aberrant homing of lymphocytes from the primary site
of autoimmune inflammation to the lung or a distinct
autoimmune process within the lungs [40]. A more recent
study has confirmed the dominance of lymphocytes in the
airways of females with idiopathic cough. In this study,
significantly elevated numbers of activated CD4+ lym-
phocytes were noted in bronchoalveolar lavage fluid from
menopausal women with isolated dry cough compared to
matched controls. This group hypothesized that meno-
pausal effects on lymphocyte activation within the airway
may lead to disordered responses to airway insults such as
infection [41].Page 3 of 5
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neuro-immune events within the airway. A number of
studies have demonstrated a heightened cough reflex sen-
sitivity in females compared to males both in healthy
individuals [42,43] and cough subjects [44]. This gender
difference has not been observed in children, raising the
possibility that sex hormones may influence the reflex
[45]. Women of post-menopausal age appear to have a
heightened cough reflex although this has not been con-
sistently demonstrated [46]. None-the-less, oestrogen lev-
els begin to decrease around the time of the menopause,
which may exert an effect on cough reflex sensitivity. Dan-
azol, a synthetic androgen that decreases oestrogen levels,
has been shown to inhibit the upregulation of the cough
reflex observed in female guinea pigs following treatment
with an ACE-inhibitor [47].
Conclusion
Although inadequate management will continue to
explain a significant number of patients with a chronic
and uncontrollable cough, an attempt has been made in
this article to highlight idiopathic cough as a distinct clin-
ical entity. Although without firm evidence, idiopathic
cough may arise as a consequence of the persisting effects
of viral infection or other noxious aggravants in suscepti-
ble individuals. The excess of middle-aged females with
idiopathic cough raises the possibility of some sex hormo-
nal influence. Precision in this area will be greatly ham-
pered unless further research is undertaken.
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